CYBA and chronic granulomatous disease: Damaging variants in genes encoding components of the NADPH oxidase complex (CYBA, CYBB, CYBC1 (49), NCF1, NCF2, and NCF4) result in impaired anti-microbial activities in phagocytes (50), and thereby chronic granulomatous disease (CGD) (51).